IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $809,041 | +8.0% | 17,836 | -2.4% | 0.01% | +10.0% |
| Q2 2023 | $749,454 | +17.0% | 18,266 | +1.9% | 0.01% | +11.1% |
| Q1 2023 | $640,711 | -4.2% | 17,927 | +1.2% | 0.01% | -18.2% |
| Q4 2022 | $668,907 | -2.6% | 17,710 | +14.0% | 0.01% | -15.4% |
| Q3 2022 | $687,000 | +20.3% | 15,540 | +0.8% | 0.01% | +18.2% |
| Q2 2022 | $571,000 | +3.4% | 15,418 | +3.5% | 0.01% | +22.2% |
| Q1 2022 | $552,000 | +21.9% | 14,898 | +0.1% | 0.01% | +28.6% |
| Q4 2021 | $453,000 | -7.4% | 14,890 | +2.2% | 0.01% | -22.2% |
| Q3 2021 | $489,000 | -19.4% | 14,572 | -4.3% | 0.01% | -18.2% |
| Q2 2021 | $607,000 | +98.4% | 15,226 | +123.8% | 0.01% | +83.3% |
| Q1 2021 | $306,000 | -20.1% | 6,803 | +0.3% | 0.01% | -25.0% |
| Q4 2020 | $383,000 | +22.8% | 6,780 | +3.2% | 0.01% | 0.0% |
| Q3 2020 | $312,000 | -22.0% | 6,571 | -3.2% | 0.01% | -20.0% |
| Q2 2020 | $400,000 | – | 6,786 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
| Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
| M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
| Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
| Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
| Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
| Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
| BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
| Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
| Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |